Related Experiment Video
Updated: Sep 3, 2025

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo
Published on: July 20, 2019
Mechanism research and treatment progress of NAD pathway related molecules in tumor immune microenvironment
QinChen Xu1, Xiaoyan Liu1, Ghazal Mohseni1
1Department of Clinical Laboratory, The Second Hospital of Shandong University, 247 Beiyuan Street, 250033, Jinan, Shandong, China.
Abstract:
Nicotinamide adenine dinucleotide (NAD) is the core of cellular energy metabolism. NAMPT, Sirtuins, PARP, CD38, and other molecules in this classic metabolic pathway affect many key cellular functions and are closely related to the occurrence and development of many diseases. In recent years, several studies have found that these molecules can regulate cell energy metabolism, promote the release of related cytokines, induce the expression of neoantigens, change the tumor immune microenvironment (TIME), and then play an anticancer role. Drugs targeting these molecules are under development or approved for clinical use. Although there are some side effects and drug resistance, the discovery of novel drugs, the development of combination therapies, and the application of new technologies provide solutions to these challenges and improve efficacy. This review presents the mechanisms of action of NAD pathway-related molecules in tumor immunity, advances in drug research, combination therapies, and some new technology-related therapies.
Insights
Nicotinamide adenine dinucleotide (NAD) pathway molecules impact cancer immunity by altering the tumor immune microenvironment (TIME). Targeting these pathways with novel drugs and combination therapies offers promising anticancer strategies.
Area of Science:
- Biochemistry
- Immunology
- Oncology
Background:
- Nicotinamide adenine dinucleotide (NAD) is central to cellular energy metabolism.
- Key molecules like NAMPT, Sirtuins, PARP, and CD38 regulate cellular functions and disease development.
- These NAD pathway molecules influence tumor immunity by modulating the tumor immune microenvironment (TIME).
Purpose of the Study:
- To review the mechanisms of NAD pathway molecules in tumor immunity.
- To summarize advances in drug research and combination therapies targeting these molecules.
- To discuss new technology-based therapies for overcoming challenges like side effects and drug resistance.
Main Methods:
- Literature review of studies on NAD pathway molecules and cancer immunity.
- Analysis of current drug development and clinical applications.
- Exploration of novel therapeutic strategies and technologies.
Main Results:
- NAD pathway molecules regulate cell energy metabolism, cytokine release, and neoantigen expression.
- These molecules significantly impact the tumor immune microenvironment (TIME), influencing anticancer effects.
- Targeted drugs show potential but face challenges like side effects and resistance.
Conclusions:
- NAD pathway modulation is a promising strategy for cancer immunotherapy.
- Advancements in drug discovery, combination therapies, and new technologies are crucial for improving efficacy.
- Further research is needed to optimize therapeutic interventions targeting the NAD pathway in cancer.
More Related Videos
Related Concept Videos
Tumor Immunotherapy
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
The Tumor Microenvironment
Targeted Cancer Therapies
There are several types of targeted therapies against...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...

